Report on verocytotoxin-producing Escherichia coli / Advisory Committee on the Microbiological Safety of Food.

  • Great Britain. Committee on the Microbiological Safety of Food. Working Group on Verocytotoxin-Producing Escherichia Coli.
Date:
1995
Catalogue details

Licence: Open Government Licence

Credit: Report on verocytotoxin-producing Escherichia coli / Advisory Committee on the Microbiological Safety of Food. Source: Wellcome Collection.

    151/164 (page 141)
    Endo Y, Tsurugi K, Yutsudo T, Takeda Y, Ogasawara T, Igarashi K. Site of action of Verocytotoxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosides activity of the toxin. Eur J Biochem 1988; 171: 45-50. Ogasawara T, Ito K, Igarashi K, Yutsudo T, Nakabayashi N, Takeda Y. Inhibition of protein synthesis by a Verocytotoxin (VT2 or Shiga-like toxin I) produced by Escherichia coli O157:H7 at the level of elongation factor 1 -dependent aminoacyl-tRNA building to ribosomes. Microbiol Pathogen 1988; 4: 127-135. Saxena S K, O’Brien A D, Ackerman E J. Shiga toxin, Shiga-like toxin IJ variant and ricin are all single-site RNA N-glycosidases of 28S RNA when micro-infected into Xenopus oocytes. J Biol Chem 1989; 264: 596-601. Van de Kar N C A J, Monnens L A H, Karmali M A, van Hinsbergh V W M. Tumour necrosis factor and interleukin-1 induce expression of the Verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the haemolytic uraemic syndrome. Blood 1992; 80: 2755-2764. Karmali M A, Steele B T, Petric M, Lim C. Sporadic cases of haemolytic uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1983; 1(8325): 619-620. Barrett T J, Green J H, Griffin P M, Pavia A T, Ostroff S M, Wachsmuth I K. Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Shiga-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr Microbiol 1991; 23: 189-195. Maloney M D, Lingwood C A. CD19 has a potential CD77 binding site with a sequence similarity to Verocytotoxin B sub-units: Implications of molecular mimicry for B cell adhesion and enterohaemorrhagic Escherichia coli pathogenesis. J Exp Med 1994; 180: 191-201. Scotland S M, Willshaw G A, Smith H R, Rowe B. Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Verocytotoxins VT1 and VT2. Epidemiol Infect 1987; 99: 613-624. Ostroff S M, Tarr P I, Neill M A, Lewis J H, Hargnett-Bean N, Kobayashi J M. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli 0157:H7 infections. J Infect Dis 1989; 160: 994-999. Tesh V L, Burris J A, Owens J E. Gordon V M, Wadolkowski E A. O’Brien A D, Samuel J E. Comparison of the relative toxicities of shiga-like toxins type I and type II for mice. Infect Immun 1993; 61: 3392-3402. Gross R J. Verocytotoxin-producing Escherichia coli 0157. PHLS Microbiol Digest 1990; 7(4): 119-123.